The goal of the proposed studies is to further explore the mechanisms by which cyclooxygenase (COX)-2, an enzyme involved in inflammatory mechanisms as well as neuronal activities, may promote neurodegeneration in the brain of a mouse model of AD-type neuropathology. Using cDNA microarray high-throughput technique, we have being exploring changes in gene expression caused by over expressing human (h)COX-2 in neurons of APPswe/PSI-A246E/hCOX-2 triple transgenic mice, obtained by crossing APPswe/PSI-A246E with mice over expressing hCOX-2 in neuron. Genes that are differentially up- or down- regulated in the brain of APPswe/PSI-A246E or APPswe/PSI-A246E/ hCOX-2, relative to wild type (WT) control littermates (and which are not regulated in hCOX-2 single transgenics), were identified and organized into functional clusters based on similarities in biological functions. One cluster of genes whose expression was selectively influenced by hCOX-2 over expression in the brain of APPswe/PS I-A246E/hCOX-2, was found to correlate with variations in cell-cycle activity and Wingless/Int-I (Wnt) pathway function. The Wnt (the name is derived from mouse Int-I and drosophila wingless) signal transduction pathway is a large family of signaling molecules including e.g. Disheveled (Dvl), Glycogen synthase kinase (GSK-3beta), and beta-catenin among others, with well-established roles in regulating cell cycle, embryonic patterning, cell proliferation and cell determination. Based on the cDNA microarray evidence we continued exploring the potential role ofhCOX-2 on indexes of cell-cycle activity and Wnt signal transduction. We found that over expression of exogenous hCOX-2 in neuron of APPswe/PSI-A246E/hCOX-2 triple transgenics leads to >3 fold elevation in the number of S795-phosphorylated tumor suppressor (pRb) protein and active caspase 3 immunopositive neurons, which are indexes of cell-cycle-activity during response to Abeta1-42 mediated apoptotic death, confirming cDNA array evidence. This evidence was confirmed in in vitro studies showing that over expression of hCOX-2 in primary cortico-hippocampal neurons derived from hCOX-2 transgenics potentiates Abeta1-42 mediated apoptotic neuron death which could be attenuated prevented by treatment of cultures with the cell-cycle dependent kinase inhibitor (CDK) flavoperidol, suggesting that COX-2 may potentiate Abeta1-42 apoptotic neuron death through activation of cell-cycle. We continued exploring these mechanisms and found that the hCOX-2 mediated potentiation of A13 1-42 apoptotic death coincided with an inhibition of Y216 -GSK-3beta phosphorylation and intracellular redistribution of beta-catenin, which is an index of activation of the Wnt signal transduction pathway, as early as four hours after Abeta1-42 treatment. The proposed studies continuing the exploration of the mechanisms by which COX-2 may promote apoptotic neuron death in a model of AD type neuropathology will clarify the role of COX-2 in inflammatory neurodegeneration during Alzheimer's disease.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG014766-07
Application #
6774771
Study Section
Special Emphasis Panel (ZRG1-BDCN-3 (02))
Program Officer
Snyder, Stephen D
Project Start
1998-08-01
Project End
2007-07-31
Budget Start
2004-08-01
Budget End
2007-07-31
Support Year
7
Fiscal Year
2004
Total Cost
$362,306
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Psychiatry
Type
Schools of Medicine
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Qin, Weiping; Haroutunian, Vahram; Katsel, Pavel et al. (2009) PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia. Arch Neurol 66:352-61
Qin, Weiping; Zhao, Wei; Ho, Lap et al. (2008) Regulation of forkhead transcription factor FoxO3a contributes to calorie restriction-induced prevention of Alzheimer's disease-type amyloid neuropathology and spatial memory deterioration. Ann N Y Acad Sci 1147:335-47
Mukherjee, Piali; Thomas, Sunil; Pasinetti, Giulio Maria (2008) Complement anaphylatoxin C5a neuroprotects through regulation of glutamate receptor subunit 2 in vitro and in vivo. J Neuroinflammation 5:5
Zhao, Zhong; Xiang, Zhongmin; Haroutunian, Vahram et al. (2007) Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer's disease. Neurobiol Aging 28:824-30
Pasinetti, Giulio Maria; Zhao, Zhong; Qin, Weiping et al. (2007) Caloric intake and Alzheimer's disease. Experimental approaches and therapeutic implications. Interdiscip Top Gerontol 35:159-75
Ho, Lap; Qin, Weiping; Stetka, Breton S et al. (2006) Is there a future for cyclo-oxygenase inhibitors in Alzheimer's disease? CNS Drugs 20:85-98
Xiang, Zhongmin; Haroutunian, Vahram; Ho, Lap et al. (2006) Microglia activation in the brain as inflammatory biomarker of Alzheimer's disease neuropathology and clinical dementia. Dis Markers 22:95-102
Pasinetti, Giulio Maria; Ho, Lap; Pompl, Patrick (2002) Amyloid immunization in Alzheimer's disease: do we promote amyloid scavenging at the cost of inflammatory degeneration? Neurobiol Aging 23:665-6
Butterfield, D Allan; Griffin, Sue; Munch, Gerald et al. (2002) Amyloid beta-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists. J Alzheimers Dis 4:193-201
Mirjany, Mana; Ho, Lap; Pasinetti, Giulio Maria (2002) Role of cyclooxygenase-2 in neuronal cell cycle activity and glutamate-mediated excitotoxicity. J Pharmacol Exp Ther 301:494-500

Showing the most recent 10 out of 16 publications